Tirzepatide Significantly Reduces HbA1c, Body Weight in Type 1 Diabetes
A new proof-of-concept observation study reports the dual GLP-1/GIP agonist's positive efficacy and safety for adults with T1D.
Source: hcplive.com
Chronic Weight News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Chronic Weight. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Chronic Weight Today - Breaking & Trending Today
Condition State Management: Diabetes
Pharmacy Times offers the latest news and insights for the pharmacy professional and solutions that impact the everyday practice of pharmacy.
Source: pharmacytimes.com
Diabetes Drug - Tirzepatide Gets FDA Approval for Weight Loss
Tirzepatide, a diabetes medication, is approved for weight loss management by FDA and is found to be very beneficial when combined with diet and exercise.
Source: medindia.net